149366-79-0 Usage
Description
3-Boc-aminomethylpyrrolidine, with the molecular formula C11H20N2O2, is an organic compound that appears as a white powder. It is widely recognized as a pharmaceutical intermediate, playing a crucial role in the synthesis of a variety of medications. This chemical is also celebrated for its applications in medicinal chemistry, where it serves as a building block for the creation of biologically active compounds. Furthermore, 3-Boc-aminomethylpyrrolidine has garnered attention for its potential in drug discovery and development, establishing it as a valuable and versatile chemical within the pharmaceutical research domain.
Uses
Used in Pharmaceutical Industry:
3-Boc-aminomethylpyrrolidine is used as a pharmaceutical intermediate for the synthesis of various medications, contributing to the development of new therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-Boc-aminomethylpyrrolidine is utilized as a building block for the production of biologically active compounds, facilitating the creation of innovative pharmaceuticals with potential health benefits.
Used in Drug Discovery and Development:
3-Boc-aminomethylpyrrolidine is employed in drug discovery and development processes, where its potential role in creating new drugs is being explored, highlighting its importance in advancing pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 149366-79-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,3,6 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 149366-79:
(8*1)+(7*4)+(6*9)+(5*3)+(4*6)+(3*6)+(2*7)+(1*9)=170
170 % 10 = 0
So 149366-79-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H20N2O2/c1-10(2,3)14-9(13)12-7-8-4-5-11-6-8/h8,11H,4-7H2,1-3H3,(H,12,13)
149366-79-0Relevant articles and documents
Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors
Pajouhesh, Hassan,Feng, Zhong-Ping,Zhang, Lingyun,Pajouhesh, Hossein,Jiang, Xinpo,Hendricson, Adam,Dong, Haiheng,Tringham, Elizabeth,Ding, Yanbing,Vanderah, Todd W.,Porreca, Frank,Belardetti, Francesco,Zamponi, Gerald W.,Mitscher, Lester A.,Snutch, Terrance P.
scheme or table, p. 4153 - 4158 (2012/07/14)
We previously reported the small organic N-type calcium channel blocker NP078585 that while efficacious in animal models for pain, exhibited modest L-type calcium channel selectivity and substantial off-target inhibition against the hERG potassium channel
3-AMINOMETHYL-PYRROLIDINES AS N-TYPE CALCIUM CHANNEL BLOCKERS
-
Page 14; 26, (2008/06/13)
The invention relates to compounds that are derivatives of 3-aminomethyl-pyrrolidine of the formulas: wherein: Y is (X2)1A or (X1)mCR4A2; W is CR4 or N; R1-R4 are noninterfering substituents; n is 0-7; 1 and m are independently 0 or 1; X1-X2 are linkers;
BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE
-
Page 79; 80, (2010/02/04)
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
